BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 33647560)

  • 1. Synthesis of one-for-all type Cu
    Wang Z; Wang Y; Guo H; Yu N; Ren Q; Jiang Q; Xia J; Peng C; Zhang H; Chen Z
    J Colloid Interface Sci; 2021 Jun; 592():116-126. PubMed ID: 33647560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clearable Theranostic Platform with a pH-Independent Chemodynamic Therapy Enhancement Strategy for Synergetic Photothermal Tumor Therapy.
    Chen Q; Luo Y; Du W; Liu Z; Zhang S; Yang J; Yao H; Liu T; Ma M; Chen H
    ACS Appl Mater Interfaces; 2019 May; 11(20):18133-18144. PubMed ID: 31046230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sub-10 nm Cu
    Wang D; Zhang Y; Guo Q
    Int J Nanomedicine; 2018; 13():7987-7996. PubMed ID: 30538472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Photothermal Therapy Nanomaterials Boosting Transformation of Fe(III) into Fe(II) in Tumor Cells for Highly Improving Chemodynamic Therapy.
    Nie X; Xia L; Wang HL; Chen G; Wu B; Zeng TY; Hong CY; Wang LH; You YZ
    ACS Appl Mater Interfaces; 2019 Sep; 11(35):31735-31742. PubMed ID: 31393101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A biocompatible theranostic agent based on stable bismuth nanoparticles for X-ray computed tomography/magnetic resonance imaging-guided enhanced chemo/photothermal/chemodynamic therapy for tumours.
    Zhao H; Wang J; Li X; Li Y; Li C; Wang X; Wang J; Guan S; Xu Y; Deng G; Chen Y; Lu J; Liu X
    J Colloid Interface Sci; 2021 Dec; 604():80-90. PubMed ID: 34265694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interfacial engineered gadolinium oxide nanoparticles for magnetic resonance imaging guided microenvironment-mediated synergetic chemodynamic/photothermal therapy.
    Zhao Z; Xu K; Fu C; Liu H; Lei M; Bao J; Fu A; Yu Y; Zhang W
    Biomaterials; 2019 Oct; 219():119379. PubMed ID: 31376746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High near-infrared absorbing Cu5FeS4 nanoparticles for dual-modal imaging and photothermal therapy.
    Zhao Q; Yi X; Li M; Zhong X; Shi Q; Yang K
    Nanoscale; 2016 Jul; 8(27):13368-76. PubMed ID: 27341480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Near-Infrared II Plasmonic Phototheranostics with Glutathione Depletion for Multimodal Imaging-Guided Hypoxia-Tolerant Chemodynamic-Photocatalytic-Photothermal Cancer Therapy Triggered by a Single Laser.
    Shan B; Liu H; Li L; Lu Y; Li M
    Small; 2022 Jan; 18(4):e2105638. PubMed ID: 34821041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel theranostic nanoplatform for complete mice tumor elimination via MR imaging-guided acid-enhanced photothermo-/chemo-therapy.
    Li B; Tang J; Chen W; Hao G; Kurniawan N; Gu Z; Xu ZP
    Biomaterials; 2018 Sep; 177():40-51. PubMed ID: 29883915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ellagic acid-Fe@BSA nanoparticles for endogenous H
    Tian Q; An L; Tian Q; Lin J; Yang S
    Theranostics; 2020; 10(9):4101-4115. PubMed ID: 32226542
    [No Abstract]   [Full Text] [Related]  

  • 11. Ultrasmall Cu
    Hu R; Fang Y; Huo M; Yao H; Wang C; Chen Y; Wu R
    Biomaterials; 2019 Jun; 206():101-114. PubMed ID: 30927714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced photoconversion performance of NdVO
    Chang M; Wang M; Shu M; Zhao Y; Ding B; Huang S; Hou Z; Han G; Lin J
    Acta Biomater; 2019 Nov; 99():295-306. PubMed ID: 31437636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Precise Tumor Photothermal Therapy Guided and Monitored by Magnetic Resonance/Photoacoustic Imaging using A Safe and pH-Responsive Fe(III) Complex.
    Liang G; Han J; Xing D
    Adv Healthc Mater; 2021 Feb; 10(3):e2001300. PubMed ID: 33314796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cu
    Yuan L; Hu W; Zhang H; Chen L; Wang J; Wang Q
    Front Bioeng Biotechnol; 2020; 8():21. PubMed ID: 32133347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multifunctional NIR-responsive poly(vinylpyrrolidone)-Cu-Sb-S nanotheranostic agent for photoacoustic imaging and photothermal/photodynamic therapy.
    Hou M; Yan C; Chen Z; Zhao Q; Yuan M; Xu Y; Zhao B
    Acta Biomater; 2018 Jul; 74():334-343. PubMed ID: 29753138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Photothermal Fenton Nanocatalysts for Synergetic Cancer Therapy in the Second Near-Infrared Window.
    Sun H; Zhang Y; Chen S; Wang R; Chen Q; Li J; Luo Y; Wang X; Chen H
    ACS Appl Mater Interfaces; 2020 Jul; 12(27):30145-30154. PubMed ID: 32515573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A highly active (102) surface-induced rapid degradation of a CuS nanotheranostic platform for in situ T
    Dong L; Li K; Wen D; Lu Y; Du K; Zhang M; Gao X; Feng J; Zhang H
    Nanoscale; 2019 Jul; 11(27):12853-12857. PubMed ID: 31265050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A light-controllable specific drug delivery nanoplatform for targeted bimodal imaging-guided photothermal/chemo synergistic cancer therapy.
    Guo Y; Wang XY; Chen YL; Liu FQ; Tan MX; Ao M; Yu JH; Ran HT; Wang ZX
    Acta Biomater; 2018 Oct; 80():308-326. PubMed ID: 30240955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intrinsically Mn2+-Chelated Polydopamine Nanoparticles for Simultaneous Magnetic Resonance Imaging and Photothermal Ablation of Cancer Cells.
    Miao ZH; Wang H; Yang H; Li ZL; Zhen L; Xu CY
    ACS Appl Mater Interfaces; 2015 Aug; 7(31):16946-52. PubMed ID: 26196160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NIR-II responsive PEGylated nickel nanoclusters for photothermal enhanced chemodynamic synergistic oncotherapy.
    Qian Y; Zhang J; Zou J; Wang X; Meng X; Liu H; Lin Y; Chen Q; Sun L; Lin W; Wang H
    Theranostics; 2022; 12(8):3690-3702. PubMed ID: 35664059
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.